Ulrich Reinhold Speck
Chief Tech/Sci/R&D Officer presso ACOTEC SCIENTIFIC HOLDINGS LIMITED
Posizioni attive di Ulrich Reinhold Speck
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACOTEC SCIENTIFIC HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 29/01/2021 | - |
Storia della carriera di Ulrich Reinhold Speck
Precedenti posizioni note di Ulrich Reinhold Speck
Società | Posizione | Inizio | Fine |
---|---|---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Founder | 01/01/2001 | 18/01/2017 |
General Counsel | 14/01/2002 | 18/01/2017 | |
Charité - Universitätsmedizin Berlin | Corporate Officer/Principal | 01/01/2000 | 01/01/2001 |
Formazione di Ulrich Reinhold Speck
Freie Universität Berlin | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 4 |
Isole Cayman | 2 |
Posizioni
Founder | 1 |
General Counsel | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Consumer Services | 3 |
Health Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ACOTEC SCIENTIFIC HOLDINGS LIMITED | Health Technology |
Aziende private | 1 |
---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Health Services |